Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

BACKGROUND: Knowledge about tumour gene mutation status is essential for the treatment of increasing numbers of cancer patients, and testing quality has a major impact on treatment response and cost. In 2012, 4,629 tests for BRAF p.V600 were performed in France, in patients with melanomas. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Emile, Jean-François, Tisserand, Julie, Bergougnoux, Loic, Nowak, Frédérique, Faucher, Gladwys, Surel, Sylvie, Lamy, Aude, Lecorre, Delphine, Helias-Rodzewicz, Zofia, Hofman, Paul, Sabourin, Jean-Christophe, Laurent-Puig, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852250/
https://www.ncbi.nlm.nih.gov/pubmed/24119386
http://dx.doi.org/10.1186/1471-2407-13-472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852250/
https://www.ncbi.nlm.nih.gov/pubmed/24119386
http://dx.doi.org/10.1186/1471-2407-13-472

Ejemplares similares